These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 11904335
1. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT. Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335 [Abstract] [Full Text] [Related]
2. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Chen YW, Jeng YM, Yeh SH, Chen PJ. Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840 [Abstract] [Full Text] [Related]
3. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Choi YW, Heath EI, Heitmiller R, Forastiere AA, Wu TT. Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797 [Abstract] [Full Text] [Related]
4. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176 [Abstract] [Full Text] [Related]
5. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426 [Abstract] [Full Text] [Related]
6. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T. Int J Oncol; 2004 May 18; 24(5):1077-83. PubMed ID: 15067328 [Abstract] [Full Text] [Related]
7. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Int J Oncol; 2002 May 18; 20(5):905-11. PubMed ID: 11956582 [Abstract] [Full Text] [Related]
8. APC mutations are infrequent but present in human lung cancer. Ohgaki H, Kros JM, Okamoto Y, Gaspert A, Huang H, Kurrer MO. Cancer Lett; 2004 Apr 30; 207(2):197-203. PubMed ID: 15072829 [Abstract] [Full Text] [Related]
9. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability. Fukushima H, Yamamoto H, Itoh F, Horiuchi S, Min Y, Iku S, Imai K. J Exp Clin Cancer Res; 2001 Dec 30; 20(4):553-9. PubMed ID: 11876551 [Abstract] [Full Text] [Related]
10. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T. Cancer Res; 2001 Sep 15; 61(18):6656-9. PubMed ID: 11559529 [Abstract] [Full Text] [Related]
11. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ. Mod Pathol; 2002 Jun 15; 15(6):617-24. PubMed ID: 12065775 [Abstract] [Full Text] [Related]
12. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM. Cancer Res; 2002 Jun 15; 62(12):3503-6. PubMed ID: 12067995 [Abstract] [Full Text] [Related]
13. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P. J Pathol; 2003 Oct 15; 201(2):250-9. PubMed ID: 14517842 [Abstract] [Full Text] [Related]
14. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG, Matías-Guiu X, Esteller M, Palacios J. Oncogene; 2002 Nov 14; 21(52):7981-90. PubMed ID: 12439748 [Abstract] [Full Text] [Related]
15. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. Sawyer EJ, Hanby AM, Rowan AJ, Gillett CE, Thomas RE, Poulsom R, Lakhani SR, Ellis IO, Ellis P, Tomlinson IP. J Pathol; 2002 Apr 14; 196(4):437-44. PubMed ID: 11920740 [Abstract] [Full Text] [Related]
16. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Kim Y, Sills RC, Houle CD. Toxicol Pathol; 2005 Apr 14; 33(1):175-80. PubMed ID: 15805069 [Abstract] [Full Text] [Related]
17. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Bläker H, Helmchen B, Bönisch A, Aulmann S, Penzel R, Otto HF, Rieker RJ. Scand J Gastroenterol; 2004 Aug 14; 39(8):748-53. PubMed ID: 15513360 [Abstract] [Full Text] [Related]
18. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. Fu X, Li J, Li K, Tian X, Zhang Y. Histopathology; 2009 Nov 14; 55(5):554-63. PubMed ID: 19912361 [Abstract] [Full Text] [Related]
19. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. Hao X, Frayling IM, Willcocks TC, Han W, Tomlinson IP, Pignatelli MN, Pretlow TP, Talbot IC. Virchows Arch; 2002 Apr 14; 440(4):362-6. PubMed ID: 11956815 [Abstract] [Full Text] [Related]
20. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J. Cancer Res; 2005 Sep 01; 65(17):7622-7. PubMed ID: 16140927 [Abstract] [Full Text] [Related] Page: [Next] [New Search]